Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Migrasome Therapeutics logo — Migrasome Therapeutics is an innovative drug research and de...

Migrasome Therapeutics

Migrasome Therapeutics is an innovative drug research and development company based on new biological discoveries.

Founded 2022 Angel Total: $100.00M Biotechnology, Health Care +1

General Information

Company Name Migrasome Therapeutics
Founded Year 2022
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Angel
Social

BounceWatch is an independent company data service, not affiliated with Migrasome Therapeutics. To contact Migrasome Therapeutics, visit migrasome.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Migrasome Therapeutics

Migrasome Therapeutics is an innovative drug research and development company based on new biological discoveries. Established in 2022, the company operates in the Biotechnology and Health Care industries. Their most recent milestone includes a CNY100.00M Angel Round investment on 26 July 2023, led by Tsinghua Capital, Beijing Capital Science and Technology Development Group, ZGC Group, and Zhongguancun Collaborative Innovation Fund. This substantial investment is a testament to the promising future of Migrasome Therapeutics and the potential impact of their research and development efforts.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Angel Round CNY100.00M 4
Tsinghua Capital
Tsinghua Capital, Beijing Capital Science and Technology Development Group +2
26 Jul 2023

Migrasome Therapeutics Alternatives & Competitors

View All Alternatives
Migrasome Therapeutics vs
Metabolon, Inc.
Metabolon, Inc. United States

Providing actionable biological insights to answer the toughest questions in life sciences research...

Grant
198 employees
Biotechnology, Health Care
Migrasome Therapeutics vs
Sanford Burnham Prebys
Sanford Burnham Prebys United States

We conduct world-class, collaborative, biological research and translate discoveries for the benefit...

786 employees
Biotechnology, Education
Migrasome Therapeutics vs
BellBrook Labs
BellBrook Labs United States

BellBrook Labs is dedicated to accelerating drug discovery and biological research.

Seed
19 employees
Biotechnology, Health Care
View all alternatives

FAQ About Migrasome Therapeutics

Migrasome Therapeutics is an innovative drug research and development company based on new biological discoveries.
Migrasome Therapeutics was founded in 2022.
Migrasome Therapeutics operates in Biotechnology, Health Care and Health and Wellness.
Migrasome Therapeutics has completed 1 funding round, raising a total of $100.00M. The latest funding stage is Angel.
Top alternatives and competitors to Migrasome Therapeutics include Metabolon, Inc., Sanford Burnham Prebys, BellBrook Labs, Cingulate Inc., Gensun Biopharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Migrasome Therapeutics and Metabolon, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Migrasome Therapeutics, https://bouncewatch.com/company/migrasome-therapeutics, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes